Ayan Chanda

12PUBLICATIONS
30CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumoursCellular nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Nov 15, 2024
VSV∆M51 drives CD8+ T cell-mediated tumour regression through infection of both cancer and non-cancer cells.

Jahanara Rajwani, Daniil Vishnevskiy, Madison Turk

|Mar 28, 2024
Targeting Oral Squamous Cell Carcinoma with Combined Polo-Like-Kinase-1 Inhibitors and γ-Radiation Therapy.

Subhanwita Sarkar, Ayan Chanda, Rutvij A Khanolkar

|Jan 12, 2023
NCBP2 and TFRC are novel prognostic biomarkers in oral squamous cell carcinoma.

Rahul Arora, Logan Haynes, Mehul Kumar

Pageof 2